The role of 5-HT in response inhibition and re-engagement

European Neuropsychopharmacology

Volumn 23, Issue 8, 2013, Pages 830-841

  Drueke, Barbara ^a   Schlaegel, Sonja M A ^a   Seifert, Anke ^a   Moeller, Olaf ^a   Gründer, Gerhard ^a,b   Gauggel, Siegfried ^a   Boecker, Maren ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Julich Aachen Research Alliance JARA   (Germany)

Author keywords

5 HT; Escitalopram; Inhibitory motor control; Stop change paradigm

Indexed keywords

ESCITALOPRAM; SEROTONIN;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; CINGULATE GYRUS; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INFERIOR FRONTAL GYRUS; INHIBITION (PSYCHOLOGY); MALE; MENTAL TASK; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; NEUROMODULATION; NORMAL HUMAN; ORBITAL CORTEX; PARIETAL CORTEX; PARIETAL LOBE; PRECUNEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RESPONSE INHIBITION; RESPONSE REENGAGEMENT; RESPONSE TIME; SEROTONINERGIC SYSTEM; SUPERIOR FRONTAL GYRUS; TASK PERFORMANCE; TEMPORAL CORTEX;

5-HT; ESCITALOPRAM; INHIBITORY MOTOR CONTROL; STOP-CHANGE PARADIGM;

ADOLESCENT; ADULT; BEHAVIOR; BRAIN; BRAIN MAPPING; CORPUS STRIATUM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; NEURAL INHIBITION; NEURONS; PREFRONTAL CORTEX; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 84881669446     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.05.005     Document Type: Article

References (44)

1. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990, 13(7):266-271.
2. Anderson, I., Clark, L., Elliott, R., Kulkarni, B., Williams, S.R, Deakin, J.F.W., 2002. 5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuro. Report 13 (12), 1547-1551.
3. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., Robbins T.W. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat. Neurosci. 2003, 6(2):115-116.
4. Aron A.R., Robbins T.W., Poldrack R.A. Inhibition and the right inferior frontal cortex. Trends Cogn. Sci. 2004, 8(4):170-177.
5. Aron A.R., Poldrack R.A. Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J. Neurosci. 2006, 26(9):2424-2433.
6. Aronson S., Delgado P. Escitalopram. Drugs Today 2004, 40(2):121-131.
7. Bari A., Eagle D.M., Mar A.C., Robinson E.S.J., Robbins T.W. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 2009, 205:273-283.
8. Boecker M., Gauggel S., Drueke B. Stop or StopChange-does it make any difference for the inhibition processs?. Int. J. Psychophysiol. 2013, 87(3):234-243.
9. Boecker M., Drueke B., Vorhold V., Knops A., Philippen B., Gauggel S. When response inhibition is followed by response re-engagement: an event related fMRI study. Hum. Brain Mapp. 2010, 32(1):94-106.
10. Boecker M., Buecheler M.M., Schroeter M.L., Gauggel S. Prefrontal brain activation during Stop-signal response inhibition: an event-related functional near-infrared spectroscopy study. Behav. Brain Res. 2007, 176(2):259-266.
11. Boehler C.N., Appelbaum L.G., Krebs R.M., Hopf J.M., Woldorff M.G. Pinning down response inhibition in the brain-conjuction analyses of the Stop signal task. Neuroimage 2010, 52:1621-1632.
12. Burke W.J., Gergel I., Bose A. Fixed dose trial of the single isomer SSRI escitalopram in depressed outpatients. Clin. Psychiatry 2002, 63:331-336.
13. Burock M.A., Buckner R.L., Woldorff M.G., Rosen B.R., Dale A.M. Randomized event-related experimental designs allow for extremely rapid presentation rates using functional MRI. NeuroReport 1998, 9:3735-3739.
14. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., Robbins T.W. Stop-signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 2005, 182:570-578.
15. Clarke H.F., Walker S.C., Dalley J.W., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb. Cortex 2007, 17(1):18-27.
16. Cools R., Roberts A.C., Robbins T.W. Serotonergic regulation of emotional and behavioural control processes. Trends Cognit. Sci. 2008, 12(1):31-40.
17. Chamberlain S.R., Fineberg N.A., Blackwell A.D., Robbins T.W., Sahakian B.J. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am. J. Psychiatry 2006, 163(7):1282-1284.
18. Chamberlain, S.R., Sahakian, B.J., 2007. The neuropsychiatry of impulsivity. Curr. Opin. Psychiatry 20 (3), 255-261.
19. Del-Ben C., Deakin J.F.W., McKie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neural responses to neuropsychological tasks in normal volunteers: an fMRI study. Neuropsychopharmacology 2005, 30:1724-1734.
20. Dougherty D.M., Richard D.M., James L.M., Mathias C.W. Effects of acute tryptophan depletion on three different types of behavioural impulsivity. Int. J. Tryptophan Res. 2010, 3:99-111.
21. Drueke B., Baetz J., Boecker M., Moeller O., Hiemle C., Gründer G., Gauggel S. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study. Psychopharmacology (Berl.) 2009, 207(2):213-223.
22. Drueke B., Boecker M., Schlaegel S., Moeller O., Hiemke C., Gründer G., Gauggel S. Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers. Hum. Psychopharmacol.: Clin. Exp. 2010, 25(6):472-480.
23. Eagle D.M., Bari A., Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl.) 2008, 199(3):439-456.
24. Evers E.A., van der Veen F.M., van Deursen J.A., Schmitt J.A., Deutz N.E., Jolles J. The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers. Psychopharmacology (Berl.) 2006, 187(2):200-208.
25. Feldman R.S., Meyer J.S., Quenzer L.F. Serotonin. Principles of Neuropsychopharmacology 1997, 345-389. Sinauer Associates, Inc. Publishers, Sunderland, Massachusetts.
26. Forman S.D., Cohen J.D., Fitzgerald M., Eddy W.F., Mintun M.A., Noll D.C. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn. Res. Med. 1995, 33:636-647.
27. Gauggel S., Rieger M., Feghoff T.A. Inhibition of ongoing responses in patients with Parkinson's disease. J. Neurol., Neurosurg. Psychiatry 2004, 75(4):539-544.
28. Hornung, J.P., 2003. The human raphe nuclei and the serotonergic system. J. Chem. Neuroanatomy 26, 331-343.
29. Kaernbach, C., 1991. Simple adaptive testing with the weighted up down method. Perception and Psychophysics, 49, 227-229.
30. Kelly A.M., Hester R., Murphy K., Javitt D.C., Foxe J.J., Garavan H. Prefrontal-subcortical dissociations underlying inhibitory control revealed by event-related fMRI. Eur. J. Neurosci. 2004, 19(11):3105-3112.
31. Li C.S., Yan P., Sinha R., Lee T.W. Subcortical processes of motor response inhibition during a stop signal task. Neuroimage 2008, 41(4):1352-1363.
32. Logan G. On the ability to inhibit thought and action: a users' guide to the stop signal paradigm. Inhibitory Processes in Attention, Memory and Language 1994, 189-239. Academic Press, San Diego. D. Dagenbach, T.H. Carr (Eds.).
33. Neubert F.-X., Mars R.B., Buch E.R., Olivier E., Rushworth M.F.S. Cortical and subcortical interactions during action reprogramming and their related white matter pathways. Proc. Natl. Acad. Sci. USA 2010, 107:13240-13245.
34. Rao N. The clinical pharmacokinetics of escitalopram. Clin. Pharmacokinet. 2007, 46(4):281-290.
35. Rieger. M., Gauggel, S., Burmeister, K., 2003. Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions. Neuropsychology 17(2), 272-82.
36. Robbins T.W. Shifting and Stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362(1481):917-932.
37. Rubia K., Smith A.B., Brammer M.J., Taylor E. Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage 2003, 20(1):351-358.
38. Rubia K., Lee F., Cleare A.J., Tunstall N., Fu C.H., Brammer M., McGuire P. Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berl.) 2005, 179(4):791-803.
39. Schacher R., Logan G.D., Robaey P., Chen S., Ickowicz A., Barr C. Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J. Abnorm. Child Psychol. 2007, 35(2):229-238.
40. Slotnick S.D., Moo L.R., Segal J.B., Hart J. Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. Brain Res. Cogn. Brain Res. 2003, 17(1):75-82.
41. Sogaard, B., Mengel, H., Rao, N., Larsen, F., 2005. The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. J. Clin. Pharmacol. 45 (12), 1400-1406.
42. Verbruggen F., Schneider D.W., Logan G.D. How to stopp and change a response: the role of goal activation in multi-tasking. J. Exp. Psychol. Hum. Percept. Perform. 2008, 34:1212-1228.
43. Völlm B., Richardson P., McKie S., Elliott R., Deakin J.F.W., Anderson I.M. Serotonergic modulation of neural responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers. Eur. J. Neurosci. 2006, 23(2):552-560.
44. Wrase J., Kahnt T., Schlagenhauf F., Beck A., Cohen M.X., Knutson B., Heinz A. Different neural systems adjust motor behavior in response to reward and punishment. Neuroimage 2007, 36:1253-1262.